Keyword: Ireland

WuXi Biologics last year picked Ireland for its first manufacturing site outside of China. Now it says it will build a vaccine plant at the same site.

Roche has spent years reprioritizing its manufacturing spending, and as part of that process, it's exiting a small molecule site in Ireland.

South Korea's SK Holdings is rolling three API operations into a new unit, SK Pharmteco, and has put its headquarters in Sacramento, California.

U.K.-based CDMO PCI Pharma Services is expanding near Dublin as part of its “robust Brexit plan for continuity of pharmaceutical supply.”

GlaxoSmithKline will unload an API plant to Thermo Fisher Scientific for €90 million. The U.S. company says it is glad to get it.

Ireland-based Nabriva had one of its new antibiotics rejected by the FDA because of problems with a contract manufacturer in Europe.

Allergan is finishing a $156.2 million investment in a biologics manufacturing facility at its Westport, Ireland, site while adding 63 jobs.  

As the appeal process could take years, the uncertainty introduces a new overhang at Perrigo, said one analyst.

U.K.-based CDMO Almac is adding to its U.S. operations with a new building at its site in North Carolina where it says it will house 100 new employees.

Gilead has opened its new $11 million manufacturing facility control lab in Ireland.